NewsMunchies

JULY 10, 2023

AI tools are gaining popularity in biomedical research because while it can take years for the pharmaceutical industry to create medicines capable of treating or curing human disease, using AI could vastly accelerate the drug-development process. AI automation opens up the possibility of faster, cheaper pharmaceuticals.

Treatment 58

Treatment Research and Development Pharmaceutical Microdosing 58

United Patients Group

MARCH 15, 2023

Cannabis is a natural treatment for pain and other symptoms of withdrawal, and has been shown to help manage the side effects of drugs and even has be used as a substitute for prescription medications. Cannabis is a natural treatment for pain and other symptoms of withdrawal. 3] Cannabis is safer than prescription drugs.

Pharmaceutical 98

Pharmaceutical Patients Chronic Pain Sleep 98

Veriheal

MAY 25, 2023

We’re talking about ketamine —a dissociative anesthetic that is featured on the World Health Organization’s List of Essential Medicines. Also known as “K,” “special K,” or “cat-valium,” ketamine is gradually climbing out of an abyss of K-fueled house parties and into the vortex of medicine.

Medicine 98

Medicine Blood Pressure Therapy Clinical Trials 98

Kind Meds (Cannabis Education Blog)

SEPTEMBER 1, 2020

One of the biggest areas of contention in the public debate about cannabis legalization is the viability of medicinal cannabis as a treatment for many mental health disorders, such as anxiety, depression, bipolar disorder, schizophrenia, and others. Cannabis Is a Unique Substance and Treatment Method.

Treatment 122

Treatment Research and Development CBD THC 122

Cannabis Law Report

FEBRUARY 14, 2020

Mind Medicine, Inc. , a Canadian biotech firm, is entering Phase II clinical trials for two experimental treatments. The other trial will test LSD microdosing as an ADHD treatment. According to its website, one trial involves an ibogaine-derived drug for treating opioid addiction.

Microdosing 45

Microdosing Treatment Medicine Clinical Trials 45

FloridaMarijuana.net

AUGUST 15, 2018

Evidence-based Complementary and Alternative Medicine published an article titled “Post-Traumatic Stress Disorder: Evidence-Based Research for the Third Millennium” which describes how profound the symptoms of PTSD can be: “Traumatic events are profoundly stressful. Get your Florida Medical Marijuana Card.

Treatment 182

Treatment Marijuana Research and Development Therapy 182

Cannabis Law Report

JUNE 24, 2021

Health minister Paulette Lenert (LSAP) responded to a parliamentary question that the country was facing three types of medicinal cannabis bottlenecks. Initially, Aurora supplied the medicines, a Canadian firm that was replaced in 2019 by Canopy Growth-Spectrum Pharmaceutics. Complementary therapy. Source: [link].

Medicine 104

Medicine Chronic Pain Treatment Patients 104

Cannabis Law Report

MARCH 9, 2022

Source: Clearmind Medicine Inc. TORONTO, March 08, 2022 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. Our aim is to develop innovative, effective and safe psychedelic-derived therapeutics that could transform the mental health pharmaceutical market,” said Clearmind CEO Adi Zuloff-Shani. About Clearmind Medicine Inc.

Medicine 52

Medicine Research and Development Pharmaceutical Treatment 52

Veriheal

SEPTEMBER 23, 2021

Fortunately, one such man, Levi Barker, provided us with some much-needed insight into what the substance is, how it is used in treatment, and more. Veriheal: How did you first get into botanical medicines and come to heal at the Iboga Wellness Center? It is then time to allow the medicine to go in and work and do its job.

Treatment 98

Treatment Medicine Research and Development Therapy 98

Kind Meds (Cannabis Education Blog)

NOVEMBER 18, 2020

In either case, there is definitely a connection, and the widening availability for adults to consume cannabis legally for recreational and medicinal purposes has driven public interest into using cannabis for mental health treatment. Between CBD and THC, CBD seems to hold the best potential as a treatment for anxiety compared to THC.

Treatment 111

Treatment Conditions CBD Clinical Trials 111

Cannabis Law Report

SEPTEMBER 28, 2021

Acupuncture is one of the safest alternative forms of treatment for chronic pain. Ideally, it should be used in combination with other therapies, such as herbal medicine and massage, and can be a great addition to other treatments. Radio Frequency Treatment. Acupuncture. First, you need to find a certified acupuncturist.

Treatment 52

Treatment Chronic Pain Therapy Tincture 52

Cannabis Law Report

JUNE 23, 2021

COPENHAGEN , June 22, 2021 /PRNewswire/ — Valcon Medical A/S (“Valcon Medical” or the “Company”), Denmark’s leading independent cannabis concentrate and medical formulation provider, received its licensing for the commercial production of cannabis from the Danish Medicines Agency (DKMA) earlier in May 2021.

Pharmaceutical 86

Pharmaceutical Concentrates Extraction Medicine 86

Veriheal

SEPTEMBER 18, 2020

Conventional forms of treatment are often accompanied by adverse side effects but there is hope for effective treatment with fewer side effects. . million of NWS Health funding for their Cannabinoid Therapeutics and Brain and Mind Centre to see if cannabidiol can be that effective treatment for spinal cord injury.

Treatment 98

Treatment Chronic Pain Research and Development CBD 98

Puff Puff Post

SEPTEMBER 25, 2019

Researchers across North America have been conducting studies on the effectiveness of Multiple Sclerosis treatment through cannabis. Currently, there is no cure for MS , and people are seeking alternative methods outside of standard pharmaceuticals and physical therapy to help treat their various symptoms. million in 2008 to 2.3

Treatment 100

Treatment Research and Development Pharmaceutical THC 100

Cannabis Info

MARCH 2, 2019

Marijuana as a treatment for epilepsy. Medical cannabis is showing great potential in the treatment of epilepsy. Cannabis has been used medicinally for thousands of years by the human race for a large catalogue of ailments. CONVENTIONAL TREATMENT. Treatment includes surgery and nutritional and lifestyle changes.

Epilepsy 69

Epilepsy Treatment Marijuana Research and Development 69

Cannabis Law Report

SEPTEMBER 24, 2019

Here is the BBC report and below you will find the full press release from GW Pharmaceuticals. T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. There are some other cannabis-based medicines that are licensed in the UK.

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

Cannabis Law Report

JULY 20, 2021

Rahn & Associates announced today that it launched new risk management solutions for the burgeoning psychedelic medicinal industry. With our new psychedelic medicinal insurance solutions, business can access the necessary coverages to protect their business, attract qualified officers/directors, and bring new treatments to market.”.

Medicine 98

Medicine Business Research and Development Chronic Pain 98

Puff Puff Post

MARCH 10, 2020

SOURCE InMed Pharmaceuticals Inc. ” Study 755-101-HV is a randomized, vehicle controlled, double-blind, Phase 1 trial, examining the safety and tolerability of two strengths of INM-755 cream in 22 healthy adult volunteers over a 14-day treatment period as part of a randomized, vehicle controlled, double-blind, Phase 1 trial.

Clinical Trials 84

Clinical Trials Pharmaceutical Research and Development Cannabinoids 84

Cannabis Law Report

MARCH 19, 2022

publishers announces the launch of Psychedelic Medicine , an influential and dynamic peer-reviewed journal supporting the growing influential research and clinical applications in this pivotal field. For further information or submission inquiries about Psychedelic Medicine , please contact us. Mary Ann Liebert Inc.,

Medicine 52

Medicine Decriminalization Pharmaceutical Topical 52

Cannabis Law Report

AUGUST 12, 2022

– August 11, 2022) – MOTAGON, a pharmaceutical company based in Prague and specializing in medical cannabis, has secured a ground-breaking agreement with Europe’s biggest indoor cannabis producer and one of the first cannabis extracts and formulations producers PHCANN INTERNATIONAL. ”

Extraction 52

Extraction Pharmaceutical Patients THC 52

Cannabis Law Report

NOVEMBER 7, 2021

WA Upper House MP Brian Walker is in the spotlight over potential conflict of interests concerns after he was appointed ‘strategic consultant’ to an ASX-listed medicinal cannabis company. Legalise Cannabis WA MP Brian Walker denies conflict over medicinal cannabis company. Cannabiz reported Friday. and Halucenex Life Sciences Inc.

Medicine 52

Medicine Clinical Trials Research and Development Pharmaceutical 52

Cannabis Law Report

SEPTEMBER 14, 2021

Depending on who you’re talking to, the plant is either an illegal and addictive narcotic, or a source of miracle treatments for everything from epilepsy, to back pain; there even some who claim it can help with depression.

Medicine 52

Medicine Epilepsy Pharmaceutical History 52

Cannabis Law Report

DECEMBER 9, 2021

08, 2021 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. Anthony Rudd, MB, BChir, FRCP, CBE is an emeritus professor of Stroke Medicine at Kings College London and recently retired as a consultant stroke physician at Guy’s and St Thomas’ Hospital. Moreau CEO of Algernon Pharmaceuticals Inc. “We Published: Dec 08, 2021.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

Cannabis Law Report

AUGUST 17, 2021

.–(BUSINESS WIRE)– $MRNS #MarinusPharma — Marinus Pharmaceuticals, Inc. We look forward to initiating our Phase 3 trial and adding to the body of evidence that supports ganaxolone’s potential as an innovative treatment option for rare epilepsies.”. Chief Medical Officer of Marinus. “We Data Highlights.

Pharmaceutical 98

Pharmaceutical Clinical Trials Treatment Patients 98

Cannabis Law Report

DECEMBER 11, 2021

A Manchester MP’s bid to open up cannabis treatments on the NHS has been blocked by Tory backbenchers in the House of Commons. 'A Despite the Government legalising medicinal cannabis in 2018, following a number of high-profile campaigns, thousands of people are still being denied access to the treatment. Read more at.

Treatment 52

Treatment Access Patients Medicine 52

Veriheal

AUGUST 12, 2021

Funded by Realm of Caring —a non-profit organization committed to redefining cannabis through research and education—this study on CBD and epilepsy was carried out as part of a joint effort with Johns Hopkins University School of Medicine researchers. 10 mg/kg/day is the current recommended maintenance dose for pharmaceutical CBD).”.

Epilepsy 66

Epilepsy Pharmaceutical Patients Sleep 66

Cannabis Law Report

SEPTEMBER 22, 2022

List Medicinal Cannabis on the PBS. The Federal Parliament legalised the use of medicinal cannabis products in Australia in February 2016, but access to treatment is still severely limited due to cost, with patients reporting average monthly costs in excess of $300 , or approximately $10 per day. He writes on his website.

Pharmaceutical 52

Pharmaceutical Media Medicine Treatment 52

Cannabis Law Report

AUGUST 10, 2022

David Pidduck , CEO, MediPharm Labs commented, “We are proud to participate in this important research that further solidifies our pharmaceutical approach to medical cannabis. There are no approved treatments or guidelines to assist clinicians in addressing end-of-life agitation in dementia. Management Commentary.

Clinical Trials 52

Clinical Trials Medicine Pharmaceutical THC 52

Cannabis Law Report

MAY 2, 2023

Australian cannabis company Cannatrek has launched a not-for-profit organisation dedicated to providing support and access to medicinal cannabis therapies for vulnerable groups. Medicinal cannabis is still quite expensive, […]

Therapy 52

Therapy Pharmaceutical Medicine Treatment 52

Cannabis Law Report

JUNE 2, 2021

The latest article in Healthcare Business Today cites the company’s Multiomics Advanced Technology™ (MAT) as the driver for more accurate predictions about disease states and individual responses to diseases and treatments that will make medicine truly personalized.

Medicine 90

Medicine Business Treatment Data 90

Cannabis Law Report

MARCH 2, 2020

The global march toward cannabis legalization has seemingly awoken another long dormant area of scientific interest: psychedelics as medicine. Food and Drug Administration (FDA) granted Breakthrough Therapy designation (BTD) to Compass Pathways ‘ psilocybin therapy for treatment-resistant depression. What’s the risk?

Medicine 59

Medicine Therapy DEA Pharmaceutical 59

Sensi Seeds

JANUARY 4, 2019

Context of the Medicinal Cannabis Situation. Since 2001, Canadians seeking to use cannabis for medical treatment have had access to it under the Marihuana Medical Access Regulations (MMAR ). Under the regulations, no intermediaries are allowed to sell medicinal cannabis to patients. The Canadian Medical Association (CMA).

Medicine 75

Medicine Research and Development Patients Programs 75

NORML

MAY 26, 2020

Thus, it enables individualization of medical cannabis regimens that can be evaluated pharmacokinetically and pharmacodynamically by accepted pharmaceutical models.” Chronic pain is the most commonly reported qualifying condition among medical cannabis patients enrolled in state-specific access programs.

Clinical Trials 250

Clinical Trials Chronic Pain Cannabinoids Patients 250

Cannabis Law Report

JUNE 28, 2021

Pharmaceutical and Medical Cannabis Leaders Zambon GmbH and Adven GmbH will Drive Medical Cannabis Supporting Treatments for Neurological Therapies. The aim of the agreement is to make medical cannabis treatments available to patients, with an initial focus on neurological therapies. The market for medical cannabis in Germany.

Access 105

Access Research and Development Pharmaceutical Therapy 105

NORML

NOVEMBER 8, 2019

This year, we can and must succeed in passing this essential legislation and protecting the rights of veterans to access medical treatment and serving those who served us. We know medical marijuana can be an effective and safe treatment for veterans and it is time to stop making them seek private, out-of-network physicians to access it.

Access 206

Access Marijuana Treatment Legislation 206

The Joint Blog

MAY 7, 2020

A multi-week treatment with cannabidiol improves biophysical and behavioral deficits associated with experimental type-1 diabetes, according to a new study. The study is titled Two-weeks treatment with cannabidiol improves biophysical and behavioral deficits associated with experimental type-1 diabetes. National Institute of Health.

Treatment 52

Treatment CBD Patients Pharmaceutical 52

Cannabis Law Report

JANUARY 16, 2020

A long-standing member of the UK Government Regulatory Agency Medicines Commission and King’s College, London professor has been appointed as chairman of the European Medicinal Cannabis Association. The European Medicinal Cannabis Association. Professor Jones. He was a Director of Allergan Inc. Source: [link].

Medicine 59

Medicine Research and Development Pharmaceutical Policy 59